The meniscus explants were fixed in Z-Fix (Anatech). Paraffin-embedded sections (5–7 µm) were stained with Safranin-O to detect glycosaminoglycan. Fast green was used as a counterstain. the following antibodies were used: MKX (HPA006927, 1:200, Sigma-Aldrich), COL1A1 (AB292, 1:200, Abcam), COL2A1 (II-II6B3-S, 1:50, DSHB), ACAN (L0101, 1:50, Assay Biotechnology), MMP13 (AB39012, 1:600, Abcam), COL10A1 (X-AC9, 1:10, DSHB) and RUNX2 (SC-390351, 1:75, Santa Cruz). Mouse IgG (I-2000, Vector Laboratories, Inc.) or Rabbit IgG (I-1000, Vector Laboratories, Inc.) were used as negative controls (fig. S16). There was only weak staining for COL1A1 and COL2A1 in DMS compared with bovine meniscus explants (fig. S17). For quantitative analysis of DAPI (H-1500 Vector Laboratories, Inc.) staining, the cells in the DMS and at the borderline between DMS in injured explants were counted. Polarized picrosirius red staining and DIC microscopy were used to detect collagen types and fiber alignment within the explants and to examine the fibrous interconnectivity between inserted DMS and injured explants. Histopathological scoring of meniscus, articular cartilage, and synovium was analyzed by previous methods (51 (link)–54 (link)).